NCS Multistage's 15min chart indicates bearish trend with MACD Death Cross, KDJ Death Cross, and Bearish Marubozu.

NCS Multistage's 15-minute chart has recently triggered several bearish indicators, including a MACD Death Cross, KDJ Death Cross, and a Bearish Marubozu, which occurred on August 11, 2022 at 10:15. This suggests that the stock price may continue to decline, as the momentum is shifting towards the downside and sellers are in control of the market. Furthermore, this bearish momentum is likely to persist, as the indicators indicate a potential further decrease in the stock price.

NCS Multistage Holdings, Inc. (NCSM) has recently encountered several bearish indicators on its 15-minute chart, which may suggest a potential decline in its stock price. On August 11, 2022, at 10:15, the stock triggered a MACD Death Cross, KDJ Death Cross, and a Bearish Marubozu, indicating a shift in momentum towards the downside and a strengthening selling pressure [1].

Despite these bearish signals, NCSM remains attractive from a valuation perspective. The stock currently holds a Zacks Rank #1 (Strong Buy) and a Value grade of A, highlighting its potential as a strong value stock [2]. Key valuation metrics, including a P/E ratio of 12.18, P/B ratio of 0.67, and P/S ratio of 0.45, are all favorable compared to its industry averages [2].

Additionally, NCSM's P/CF ratio of 4.77 is lower than the industry average of 6.37, suggesting that the stock may be undervalued based on its cash flow outlook [2]. Over the past year, NCSM's P/CF has ranged from 0.93 to 8.09, with a median of 4.72, further indicating its potential undervaluation.

Moreover, recent insider activity provides additional context. On August 4 and 5, 2025, Mitchell Valerie A, a Director at NCS Multistage, sold 2,517 shares of Common Stock for a total of $75,825, with weighted average prices ranging from $30.00 to $30.69 [2]. While this sale may indicate some concern, it is essential to consider the broader picture and the stock's fundamentals.

In summary, while NCS Multistage faces bearish technical indicators, its strong valuation metrics and potential undervaluation suggest that investors should closely monitor the stock. Further analysis and market conditions will be crucial in determining the stock's future performance.

References:
[1] https://www.nasdaq.com/articles/ncs-multistage-ncsm-stock-undervalued-right-now
[2] https://www.tradingview.com/news/tradingview:d1cc41805a90b:0-ncs-multistage-holdings-director-sells-shares/